Four Guardians

Four Guardians is a dynamic biotechnology company committed to advancing innovative solutions for global health challenges. Focused on the development and commercialization of groundbreaking antiviral drugs, Four Guardians is dedicated to improving the lives of patients worldwide. Located in AVALON, NSW, at Primary: P O Box 359, AVALON, NSW 2107, AU, the company operates with a passion for scientific excellence and a commitment to addressing unmet medical needs.

Four Guardians specializes in the development of DG35/17 Prodrug, an innovative antiviral drug with a proven track record in clinical studies and human trials. The company's expertise extends to creating water-soluble, low-dose prodrugs that offer improved efficacy and reduced side effects compared to traditional protease inhibitors. By focusing on patient well-being and quality of life, Four Guardians is poised to make a significant impact in the treatment of HIV/AIDS and other viral infections.

With a forward-looking approach, Four Guardians is actively seeking strategic partnerships and investment opportunities to complete clinical trials and bring its groundbreaking drug to market. The company's commitment to innovation and patient-centric solutions positions it as a key player in the biotechnology industry. We invite the manager of Four Guardians to create a customized and exclusive company showcase and product listing on our platform to further enhance its commercial development.